Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now

Go-To-Market Strategy

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Identification of GTM Strategies through Primary Intelligence. Assessment of manufacturing sites, partners & logistics and distribution networks.

Problem Statement:

A medium pharmaceutical client based in the United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe through Competitive Assessment of their EU based competitors in the same area of interest. They wished to identify manufacturing sites, logistic operations, distribution network, salesforce assessment and their sales targets

Our Methodology:
  • DelveInsight conducted secondary and primary research to assess the landscape of Biosimilars in the European region
  • Sources like companies’ websites, clinical trials websites, press releases, literature reviews and research publications along with the internal resources were utilised.
  • DelveInsight conducted extensive primary research to identify the commercial process of launching a biosimilar in Europe, pricing approval process, the partnerships between companies, and the countries with increased ease of biosimilar launch.

DelveInsight conducted Due Diligence on the biosimilar landscape in Europe and targeted the top biosimilar companies for primary assessment to research for Go-to-market strategies

  • DelveInsight provided an in-depth evaluation of the approval and launch sequence.
  • The client received a list of launch priority in terms of geography.
  • Listing of promotional activities conducted by the companies.
  • Deployment of marketing and promotional personnel and target assessment for promotional material for successful launch and uptake

DelveInsight’s extensive and pro-active approach in understanding marketing strategies and launch assessment helped the client understand the biosimilar market of Europe and best positioned them for a successful journey towards commercialisation of their products in the European region.

Related Insights

Partner Identification
Partner Identification

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. [...]

View Case
Market & Competitive Assessment
Market & Competitive Assessment

A large Asian conglomerate was working to develop their asset portfolio in Cell Imaging and Analysis, and was interested to assess the market scenario of software based devices in... [...]

View Case
Market Assessment
Market Assessment

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new class of drug showed the potential in targeting multiple... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.